Cann Group Ltd (AU:CAN) — Market Cap & Net Worth
Market Cap & Net Worth: Cann Group Ltd (CAN)
Cann Group Ltd (AU:CAN) has a market capitalization of $4.70 Million (AU$6.64 Million) as of September 20, 2026. Listed on the AU stock exchange, this Australia-based company holds position #28799 globally and #1549 in its home market, demonstrating a -20.00% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cann Group Ltd's stock price AU$0.00 by its total outstanding shares 1660593585 (1.66 Billion). Also see Cann Group Ltd assets under control for a full breakdown of the balance sheet.
Cann Group Ltd Market Cap History: 2017 to 2026
Cann Group Ltd's market capitalization history from 2017 to 2026. Data shows change from $3.19 Billion to $4.70 Million (-41.78% CAGR). Also see Cann Group Ltd (CAN) cash flow conversion for how efficiently the company converts equity into cash flow.
Cann Group Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cann Group Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check CAN stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.80x
Cann Group Ltd's market cap is 0.80 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $3.19 Billion | $8.42K | -$2.59 Million | 379254.43x | N/A |
| 2018 | $2.39 Billion | $605.65K | -$4.73 Million | 3945.26x | N/A |
| 2019 | $734.36 Million | $2.61 Million | -$10.93 Million | 281.59x | N/A |
| 2020 | $687.71 Million | $647.22K | -$16.94 Million | 1062.56x | N/A |
| 2021 | $338.04 Million | $4.29 Million | -$25.10 Million | 78.74x | N/A |
| 2022 | $238.99 Million | $6.41 Million | -$26.47 Million | 37.28x | N/A |
| 2023 | $113.97 Million | $13.78 Million | -$33.79 Million | 8.27x | N/A |
| 2024 | $45.82 Million | $15.37 Million | -$51.24 Million | 2.98x | N/A |
| 2025 | $10.57 Million | $13.25 Million | -$22.34 Million | 0.80x | N/A |
Competitor Companies of CAN by Market Capitalization
Companies near Cann Group Ltd in the global market cap rankings as of September 20, 2026. Review CAN tangible net assets ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Cann Group Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #613 globally with a market cap of $44.92 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #635 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #670 globally with a market cap of $40.99 Billion USD ( CN¥280.10 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #613 | GALDERMA GROUP AG | NYSE:GALDY | $44.92 Billion | $38.53 |
| #635 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.90 |
| #670 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $40.99 Billion | CN¥43.91 |
Cann Group Ltd Historical Marketcap From 2017 to 2026
Between 2017 and today, Cann Group Ltd's market cap moved from $3.19 Billion to $ 4.70 Million, with a yearly change of -41.78%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$4.70 Million | -55.56% |
| 2025 | AU$10.57 Million | -76.92% |
| 2024 | AU$45.82 Million | -59.79% |
| 2023 | AU$113.97 Million | -52.31% |
| 2022 | AU$238.99 Million | -29.30% |
| 2021 | AU$338.04 Million | -50.85% |
| 2020 | AU$687.71 Million | -6.35% |
| 2019 | AU$734.36 Million | -69.27% |
| 2018 | AU$2.39 Billion | -25.18% |
| 2017 | AU$3.19 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of Cann Group Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.70 Million USD |
| MoneyControl | $4.70 Million USD |
| MarketWatch | $4.70 Million USD |
| marketcap.company | $4.70 Million USD |
| Reuters | $4.70 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Cann Group Ltd
Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia.